230 related articles for article (PubMed ID: 26666816)
41. NVP-BEZ235, a novel dual PI3K-mTOR inhibitor displays anti-glioma activity and reduces chemoresistance to temozolomide in human glioma cells.
Yu Z; Xie G; Zhou G; Cheng Y; Zhang G; Yao G; Chen Y; Li Y; Zhao G
Cancer Lett; 2015 Oct; 367(1):58-68. PubMed ID: 26188279
[TBL] [Abstract][Full Text] [Related]
42. Akt and β-catenin contribute to TMZ resistance and EMT of MGMT negative malignant glioma cell line.
Yi GZ; Liu YW; Xiang W; Wang H; Chen ZY; Xie SD; Qi ST
J Neurol Sci; 2016 Aug; 367():101-6. PubMed ID: 27423571
[TBL] [Abstract][Full Text] [Related]
43. The effect and mechanism of CXCR4 silencing on metastasis suppression of human glioma U87 cell line.
Zhu Y; Yang P; Zhang X; Zhang L; Cui G; Wang Q; Lv L; Zhang Y; Xin X; Yan T; Zhao M; Zhang N
Anat Rec (Hoboken); 2013 Dec; 296(12):1857-64. PubMed ID: 24249397
[TBL] [Abstract][Full Text] [Related]
44. Protein alterations associated with temozolomide resistance in subclones of human glioblastoma cell lines.
Sun S; Wong TS; Zhang XQ; Pu JK; Lee NP; Day PJ; Ng GK; Lui WM; Leung GK
J Neurooncol; 2012 Mar; 107(1):89-100. PubMed ID: 21979894
[TBL] [Abstract][Full Text] [Related]
45. CIP2A is overexpressed in human ovarian cancer and regulates cell proliferation and apoptosis.
Fang Y; Li Z; Wang X; Zhang S
Tumour Biol; 2012 Dec; 33(6):2299-306. PubMed ID: 22923389
[TBL] [Abstract][Full Text] [Related]
46. MicroRNA-106b promotes pituitary tumor cell proliferation and invasion through PI3K/AKT signaling pathway by targeting PTEN.
Zhou K; Zhang T; Fan Y; Serick ; Du G; Wu P; Geng D
Tumour Biol; 2016 Oct; 37(10):13469-13477. PubMed ID: 27465551
[TBL] [Abstract][Full Text] [Related]
47. Overexpression of WWP1 promotes tumorigenesis and predicts unfavorable prognosis in patients with hepatocellular carcinoma.
Zhang XF; Chao J; Pan QZ; Pan K; Weng DS; Wang QJ; Zhao JJ; He J; Liu Q; Jiang SS; Chen CL; Zhang HX; Xia JC
Oncotarget; 2015 Dec; 6(38):40920-33. PubMed ID: 26506518
[TBL] [Abstract][Full Text] [Related]
48. Metastasis tumor-associated protein-2 knockdown suppresses the proliferation and invasion of human glioma cells in vitro and in vivo.
Cheng CY; Chou YE; Ko CP; Yang SF; Hsieh SC; Lin CL; Hsieh YH; Chen KC
J Neurooncol; 2014 Nov; 120(2):273-81. PubMed ID: 25048531
[TBL] [Abstract][Full Text] [Related]
49. Frequent Nek1 overexpression in human gliomas.
Zhu J; Cai Y; Liu P; Zhao W
Biochem Biophys Res Commun; 2016 Aug; 476(4):522-527. PubMed ID: 27251576
[TBL] [Abstract][Full Text] [Related]
50. Low c-Met expression levels are prognostic for and predict the benefits of temozolomide chemotherapy in malignant gliomas.
Li MY; Yang P; Liu YW; Zhang CB; Wang KY; Wang YY; Yao K; Zhang W; Qiu XG; Li WB; Peng XX; Wang YZ; Jiang T
Sci Rep; 2016 Feb; 6():21141. PubMed ID: 26879272
[TBL] [Abstract][Full Text] [Related]
51. Rsf-1, a chromatin remodeling protein, induces DNA damage and promotes genomic instability.
Sheu JJ; Guan B; Choi JH; Lin A; Lee CH; Hsiao YT; Wang TL; Tsai FJ; Shih IeM
J Biol Chem; 2010 Dec; 285(49):38260-9. PubMed ID: 20923775
[TBL] [Abstract][Full Text] [Related]
52. Gab2 expression in glioma and its implications for tumor invasion.
Shi L; Sun X; Zhang J; Zhao C; Li H; Liu Z; Fang C; Wang X; Zhao C; Zhang X; Zhou F; Lu S; Luo R; Zhang B
Acta Oncol; 2013 Nov; 52(8):1739-50. PubMed ID: 23231021
[TBL] [Abstract][Full Text] [Related]
53. Triptolide synergistically enhances temozolomide-induced apoptosis and potentiates inhibition of NF-κB signaling in glioma initiating cells.
Sai K; Li WY; Chen YS; Wang J; Guan S; Yang QY; Guo CC; Mou YG; Li WP; Chen ZP
Am J Chin Med; 2014; 42(2):485-503. PubMed ID: 24707876
[TBL] [Abstract][Full Text] [Related]
54. Expression of far upstream element (FUSE) binding protein 1 in human glioma is correlated with c-Myc and cell proliferation.
Ding Z; Liu X; Liu Y; Zhang J; Huang X; Yang X; Yao L; Cui G; Wang D
Mol Carcinog; 2015 May; 54(5):405-15. PubMed ID: 24347226
[TBL] [Abstract][Full Text] [Related]
55. CHI3L1 (YKL-40) is expressed in human gliomas and regulates the invasion, growth and survival of glioma cells.
Ku BM; Lee YK; Ryu J; Jeong JY; Choi J; Eun KM; Shin HY; Kim DG; Hwang EM; Yoo JC; Park JY; Roh GS; Kim HJ; Cho GJ; Choi WS; Paek SH; Kang SS
Int J Cancer; 2011 Mar; 128(6):1316-26. PubMed ID: 20506295
[TBL] [Abstract][Full Text] [Related]
56. miR-656 inhibits glioma tumorigenesis through repression of BMPR1A.
Guo M; Jiang Z; Zhang X; Lu D; Ha AD; Sun J; Du W; Wu Z; Hu L; Khadarian K; Shen J; Lin Z
Carcinogenesis; 2014 Aug; 35(8):1698-706. PubMed ID: 24480809
[TBL] [Abstract][Full Text] [Related]
57. Impact of MACC1 on human malignant glioma progression and patients' unfavorable prognosis.
Hagemann C; Fuchs S; Monoranu CM; Herrmann P; Smith J; Hohmann T; Grabiec U; Kessler AF; Dehghani F; Löhr M; Ernestus RI; Vince GH; Stein U
Neuro Oncol; 2013 Dec; 15(12):1696-709. PubMed ID: 24220141
[TBL] [Abstract][Full Text] [Related]
58. Embryonic stem cell (ESC)-mediated transgene delivery induces growth suppression, apoptosis and radiosensitization, and overcomes temozolomide resistance in malignant gliomas.
Germano IM; Emdad L; Qadeer ZA; Binello E; Uzzaman M
Cancer Gene Ther; 2010 Sep; 17(9):664-74. PubMed ID: 20523363
[TBL] [Abstract][Full Text] [Related]
59. ZNF217 is overexpressed and enhances cell migration and invasion in colorectal carcinoma.
Zhang ZC; Zheng LQ; Pan LJ; Guo JX; Yang GS
Asian Pac J Cancer Prev; 2015; 16(6):2459-63. PubMed ID: 25824781
[TBL] [Abstract][Full Text] [Related]
60. MiR-16 modulate temozolomide resistance by regulating BCL-2 in human glioma cells.
Han J; Chen Q
Int J Clin Exp Pathol; 2015; 8(10):12698-707. PubMed ID: 26722459
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]